Celyad Oncology (XBRU:CYAD) Days Inventory: (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Celyad Oncology Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Celyad Oncology's Average Total Inventories for the six months ended in Dec. 2025 was €0.26 Mil. Celyad Oncology's Cost of Goods Sold for the six months ended in Dec. 2025 was € Mil.

The historical rank and industry rank for Celyad Oncology's Days Inventory or its related term are showing as below:

XBRU:CYAD' s Days Inventory Range Over the Past 10 Years
Min: 11708.08   Med: 15366.86   Max: 19025.63
Current: 15330

During the past 13 years, Celyad Oncology's highest Days Inventory was 19025.63. The lowest was 11708.08. And the median was 15366.86.

XBRU:CYAD's Days Inventory is ranked worse than
99.22% of 638 companies
in the Biotechnology industry
Industry Median: 184.675 vs XBRU:CYAD: 15330.00

Celyad Oncology's Days Inventory declined from Dec. 2024 (339.74) to Dec. 2025 ().

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Celyad Oncology's Inventory Turnover for the six months ended in Dec. 2025 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Celyad Oncology's Inventory-to-Revenue for the six months ended in Dec. 2025 was 36.43.

Celyad Oncology  (XBRU:CYAD) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Celyad Oncology's Inventory Turnover for the six months ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
= / 0.255
=0.00

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Celyad Oncology's Inventory to Revenue for the six months ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.255 / 0.007
=36.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Celyad Oncology Days Inventory Related Terms

Celyad Oncology Days Inventory Historical Data

* Premium members only.

The historical data trend for Celyad Oncology's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celyad Oncology Days Inventory Chart

Celyad Oncology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Celyad Oncology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 339.74 289.25 -

XBRU:CYAD vs VRTX, REGN, MRNA: Days Inventory Comparison

For the Biotechnology subindustry, Celyad Oncology's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celyad Oncology Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celyad Oncology's Days Inventory distribution charts can be found below:

* The bar in red indicates where Celyad Oncology's Days Inventory falls into.


Celyad Oncology Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Celyad Oncology's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.417 + 0) / 1 ) / -1.91*365
=0.417 / -1.91*365
=N/A

Celyad Oncology's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2025 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0.255 + 0) / 1 ) / *365 / 2
=0.255 / *365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celyad Oncology Business Description

Other Exchanges CLYYF:USA0QFK:UK1C0:Germany
Address Rue Edouard Belin 2, Axis Business Park, Brabant Wallon, Mont-Saint-Guibert, BEL, 1435
Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of technologies for chimeric antigen receptor T-cell (CAR T) therapies. The company focuses on solid tumors and hematological malignancies. The firm has CYAD-01 and CYAD-02 programs in the pipeline. The company owns trademarks and service marks, including CELYAD, C-CATH, C_CURE, CAR-T Cell, THINK, CYAD01 - Deplethink, CYAD02 - Cycle1, CwalityCAR, CYAD-101, and new engagers. The firm has Cardiology and Immuno-oncology operating segments. It generates the majority of its revenue from the Cardiology segment.